M. J. Biopharm Private Limited Pyrazinamide Export Data — India (DGFT 2022–2026)

Name: M. J. Biopharm Private Limited Pyrazinamide Export Records India — #11 Exporter, 6 Shipments, $171.1K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Pyrazinamide

India Pharmaceutical Trade Intelligence

$962.4M90 Suppliers131 CountriesHS 30049057

ExportsIndia → CONGO DR55.5%India → NIGERIA26.0%

ImportsUNITED STATES → India$5.0K GERMANY → India$2.6K

#1 Supplier: LUPIN LIMITED #1 Buyer: NATIONAL TUBERCULOSIS

M. J. Biopharm Private Limited — Pyrazinamide Exporter #11 | $171.1K Trade Value | TransData Nexus | TransData Nexus

M. J. Biopharm Private Limited — Pyrazinamide Exporter Profile

Indian Pharmaceutical Exporter · #11 for Pyrazinamide · $171.1K export value · DGFT Verified

M. J. Biopharm Private Limited is the #11 Indian exporter of Pyrazinamide with $171.1K in export value and 6 verified shipments. M. J. Biopharm Private Limited holds a 0.0% market share in Pyrazinamide exports across 1 countries. The company exports 6 pharmaceutical products worth $22.4M across 4 therapeutic categories.

M. J. Biopharm Private Limited — Pyrazinamide Export Profile: Buyers & Destinations

M. J. Biopharm Private Limited Pyrazinamide export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Pyrazinamide?

Country	Value	Shipments	Share
SOUTH AFRICA	$5.8M	116	21.4%
NETHERLANDS	$5.3M	106	19.6%
PHILIPPINES	$3.1M	62	11.4%
NIGERIA	$2.8M	55

Who Are the Top Buyers of Pyrazinamide from India?

Buyer	Country	Value	Orders
I+SOLUTIONS	NETHERLANDS	$2.6M	52
NATIONAL TUBERCULOSIS AND LEPROSY	NIGERIA	$1.7M	34
SEKRETARIAT DITJEN PENCEGAHAN DAN P	INDONESIA	$850.0K	17
KENYA MEDICAL SUPPLIES AGENCY	KENYA	$450.0K	9
DEPARTMENT OF HEALTH	PHILIPPINES	$350.0K	7
NATIONAL TB CONTROL PROGRAM,PAKISTA	PAKISTAN	$350.0K	7
MINISTRY OF HEALTH OF THE REPUBLIC	ZAMBIA	$300.0K	6
LA PHARMACIE CENTRALE DE TUNISIE	TUNISIA	$150.0K	3
MINISTERIO DA SAUDE/DEPARTAMENTO DE	BRAZIL	$150.0K	3
CENTRAL DE MEDICAMENTOS Y ARTIGOS M	MOZAMBIQUE	$150.0K	3

India's Pyrazinamide is purchased by 434 buyers worldwide. The top buyer is I+SOLUTIONS (NETHERLANDS), followed by NATIONAL TUBERCULOSIS AND LEPROSY and SEKRETARIAT DITJEN PENCEGAHAN DAN P.

How Does M. J. Biopharm Private Limited Compare to Nearest Pyrazinamide Exporters?

Exporters ranked immediately above and below #11 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
9	OMNICALS PHARMA PRIVATE LIMITED	$275.2K	9	2	$30.6K
10	SIMPEX PHARMA PRIVATE LIMITED	$194.8K	6	1	$32.5K
11	M. J. BIOPHARM PRIVATE LIMITED ★	$171.1K	6	1	$28.5K
12	DEUTSCHE LABS INC.	$150.0K	3	1	$50.0K
13	PHAR & VIDE	$138.0K	4	2	$34.5K

M. J. Biopharm Private Limited ranks #11 among 90 Indian Pyrazinamide exporters. Average shipment value of $28.5K compared to the market average of $557.3K. The closest competitors by value are OMNICALS PHARMA PRIVATE LIMITED and SIMPEX PHARMA PRIVATE LIMITED.

Which Indian Ports Ship Pyrazinamide Exports?

Port	Shipments	% Share
SAHAR AIR	357	24.5%
SAHAR AIR CARGO ACC (INBOM4)	170	11.7%
DELHI AIR	154	10.6%
DELHI AIR CARGO ACC (INDEL4)	126	8.6%
Bombay Air	94	6.4%
NHAVA SHEVA SEA (INNSA1)	87	6.0%
JNPT	87	6.0%
JNPT/ NHAVA SHEVA SEA	81	5.6%

Geopolitical & Trade Policy Impact on M. J. Biopharm Private Limited's Pyrazinamide Exports

The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like M. J. Biopharm. Escalating tensions in the Middle East, particularly the Israel-Iran conflict, have disrupted key shipping routes through the Red Sea and the Suez Canal. Major carriers have suspended or rerouted shipments, leading to increased transit times and freight costs. This situation poses significant logistical hurdles for time-sensitive pharmaceutical exports. (livemint.com)

Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, potentially benefiting Indian exporters. However, the U.S. has also implemented policies favoring domestic manufacturing, such as the "Buy American" initiative, which could impact Indian companies' access to this lucrative market. (walterhealthcare.co.in)

In the European Union, stringent regulations like the Falsified Medicines Directive necessitate rigorous compliance from exporters. Indian companies must navigate these complex requirements to maintain market access, emphasizing the need for robust quality assurance systems. (ipa-india.org)

M. J. Biopharm Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set stringent guidelines to ensure product safety and efficacy. Indian companies have faced challenges, including increased compliance costs and potential reductions in export volumes due to evolving regulations. (transdatanexus.com)

For M. J. Biopharm, maintaining adherence to these standards is crucial to sustain and expand its export markets. Investments in quality control, staff training, and infrastructure are essential to meet the evolving requirements and to build trust with international partners and regulatory bodies.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Pyrazinamide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: M. J. Biopharm Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 131+ countries, 434+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Pyrazinamide

Pyrazinamide

M. J. Biopharm Private Limited — Pyrazinamide Exporter Profile

M. J. Biopharm Private Limited — Pyrazinamide Export Profile: Buyers & Destinations

Where Does India Export Pyrazinamide?

Who Are the Top Buyers of Pyrazinamide from India?

What Is India's Total Pyrazinamide Export Value and How Much Does M. J. Biopharm Private Limited Contribute?

What Is the Average Shipment Value for M. J. Biopharm Private Limited's Pyrazinamide Exports?

How Does M. J. Biopharm Private Limited Compare to Other Indian Pyrazinamide Exporters?

Regulatory Requirements: Exporting Pyrazinamide to Key Markets

South Africa — SAHPRA

Nigeria — NAFDAC

How Does M. J. Biopharm Private Limited Compare to Nearest Pyrazinamide Exporters?

Which Indian Ports Ship Pyrazinamide Exports?

What Other Tuberculosis Medications Products Does M. J. Biopharm Private Limited Export?

Geopolitical & Trade Policy Impact on M. J. Biopharm Private Limited's Pyrazinamide Exports

M. J. Biopharm Private Limited — Regulatory Compliance & Quality Standards

About M. J. Biopharm Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Pyrazinamide Export Data from M. J. Biopharm Private Limited

Pyrazinamide Stats

Company Overview

Top Products by M. J. Biopharm Private Limited

Related Analysis

Need Detailed Export Data?

Data Source